Crossmark

Self-RNA Rmrp pre-dimerizes TLR3 for immune activation

Crossref DOI link: https://doi.org/10.1038/s41422-025-01184-7

Published Online: 2025-09-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Han, Ailin

Flavell, Richard A. https://orcid.org/0000-0003-4461-0778
License Information

Text and Data Mining valid from 2025-09-29

Version of Record valid from 2025-09-29
More Information

Article History

First Online: 29 September 2025

Competing interests

: R.A.F. is a consultant for Odyssey Therapeutics, GlaxoSmithKline, and a Founder and Scientific advisor for Ventus Therapeutics and Prelon Therapeutics.